Cancer

Evidence-based screening targets specific cancers in defined groups; no scan or blood panel screens reliably for every cancer.

Last updated October 2026 · New Dawn Health editorial team

How common
A leading cause of death worldwide
Biggest risk factor
Age — the median age at diagnosis is 67 (US data)
Usually silent?
Early cancers often cause no symptoms
How it's screened
Cancer-specific tests for defined populations

What is cancer?

Cancer is a group of diseases in which abnormal cells divide out of control, invade nearby tissue, and can spread to distant parts of the body. It is more than 100 diseases, each named for the organ or tissue where it starts, or for the type of cell involved.

A doctor talks through options with a middle-aged man across a consultation desk.
Which cancers are worth looking for depends on your age, history and family.

Why early detection matters

Many cancers are easier to treat when they are found small and before they spread. But screening helps only when its benefits outweigh its harms in a defined group: fewer deaths, less illness, or, for cervical and colorectal screening, cancers prevented. Outside those groups, the harms can outweigh the benefit.

What raises your risk

Risk comes from factors you cannot change and several you can:

  • Age — the biggest factor. In US data the median age at diagnosis is 67.
  • Family history and inherited genes — these raise the risk of specific cancers
  • Tobacco — the largest factor you can change, driving lung and several other cancers
  • Alcohol and excess weight — both linked to several cancers
  • Chronic infections — HPV, hepatitis B and C, and H. pylori in the stomach

Having a risk factor does not mean you will get cancer. Many people who develop it have none of the obvious ones, which is why age-based screening still matters when you feel well.

Which screening tests work

Recommended screening tests with evidence of benefit in the right groups
  • Breast: mammography — USPSTF (US) and Taiwan's HPA, women 40–74 every 2 years
  • Colorectal: a stool test (FIT) or colonoscopy — USPSTF 45–75; Taiwan screens with FIT
  • Lung: low-dose CT lowers lung-cancer deaths in heavy smokers (NLST). Taiwan also screens people with a family history, where the evidence is detection (TALENT), not fewer deaths.
  • Cervical: Pap and HPV tests — USPSTF and HPA
Not a substitute for those tests
  • Whole-body MRI. The American College of Radiology (2023) says there is no documented evidence it prolongs life. The tests on the left remain the screens for those cancers.
  • Tumor markers such as CEA and CA 19-9. The US National Cancer Institute says they do not work well for screening. Imaging or a biopsy answers a specific question instead.
  • PSA for prostate cancer. The USPSTF (US) calls it an individual decision at 55–69 and recommends against it from 70. The blood panel page explains why.

Who is screened in Taiwan

Taiwan's Health Promotion Administration (HPA) runs national programs for these groups. Funded screening is for people with National Health Insurance who meet the criteria:

Taiwan's national cancer screening programs, from 2025 (gastric from 2026).
Cancer Test Who, and how often
Colorectal Stool test (FIT) Ages 45–74 every 2 years; ages 40–44 every 2 years if a parent, child or sibling has had colorectal cancer
Breast Mammography Women 40–74 every 2 years
Cervical Pap smear; HPV test Pap ages 25–29 every 3 years; from 30, subsidized yearly (HPA recommends at least every 3 years). HPV test once at each of 35, 45 and 65
Lung Low-dose CT Every 2 years with a parent, sibling or child with lung cancer (men 45–74, women 40–74). Also smokers 50–74 with 20+ pack-years (one pack a day for 20 years, or the equivalent) who currently smoke and are willing to quit, or who quit less than 15 years ago
Oral Visual mouth exam Every 2 years for people 30 and over who smoke or chew/chewed betel nut; Indigenous people 18–29 who chew/chewed betel nut
Stomach H. pylori stool test Once, at 45–74. It tests for the infection, not for cancer.

Short-term visitors are not covered by Taiwan's National Health Insurance, so screening is self-funded. The table is still a fair guide to who Taiwan screens.

  • Heavy or uncontrolled bleeding, coughing or vomiting blood, or bleeding with fainting, weakness or trouble breathing: In Taiwan call 119 (the local equivalent of 911).
  • A lump, unexplained weight loss, bleeding or a persistent change: see a doctor soon. Symptoms need diagnosis, not a screening package.
  • No symptoms: match yourself to the table, and ask about earlier screening if a close relative had cancer young.
  • An abnormal result: it needs diagnostic follow-up. How that is arranged is confirmed for your booking.

Sources & further reading

  1. [1] Taiwan national cancer screening programs — FIT 45–74 every 2 years (40–44 if a parent, child or sibling had colorectal cancer); mammography 40–74 every 2 years; Pap 25–29 every 3 years, yearly from 30; HPV at 35, 45, 65; lung LDCT two groups; oral every 2 years from 30 (Indigenous 18–29); H. pylori 45–74 from 2026 — Health Promotion Administration, Ministry of Health and Welfare (Taiwan)
  2. [2] Cancer — key facts: a leading cause of death worldwide — World Health Organization
  3. [3] Age and cancer risk — median age at diagnosis 67 (SEER) — National Cancer Institute
  4. [4] What Is Cancer? — National Cancer Institute
  5. [5] Cancer screening tests — which have been shown to reduce deaths — National Cancer Institute
  6. [6] Breast Cancer: Screening (2024) — biennial mammography, women 40–74 — US Preventive Services Task Force
  7. [7] Colorectal Cancer: Screening (2021) — adults 45–75 — US Preventive Services Task Force
  8. [8] Lung Cancer: Screening (2021) — adults 50–80, 20 pack-years, smoking now or quit within 15 years — US Preventive Services Task Force
  9. [9] National Lung Screening Trial (NLST): 20% fewer lung-cancer deaths with low-dose CT in heavy smokers (NEJM 2011) — PubMed
  10. [10] TALENT: low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan (Chang 2024) — detection, not mortality — Lancet Respiratory Medicine / PubMed
  11. [11] Cervical Cancer: Screening (2018) — ages 21–65 — US Preventive Services Task Force
  12. [12] Prostate Cancer: Screening (2018) — individual decision at 55–69 — US Preventive Services Task Force
  13. [13] Tumor Markers — fact sheet: markers do not work well for screening — National Cancer Institute
  14. [14] ACR statement on screening total body MRI (2023) — American College of Radiology

Cancer — Frequently Asked Questions

Is there one test that screens for all cancers?

No. Each proven screening test targets one cancer. Mammography screens the breast, a stool test or colonoscopy the bowel, and Pap and HPV tests the cervix. Low-dose CT screens the lungs in eligible people. No single scan replaces them.

Can a blood test detect cancer?

Not as a general screen. The US National Cancer Institute says tumor markers such as CEA and CA 19-9 do not work well for screening. PSA is a blood test the USPSTF (US) treats as an individual decision for men 55–69: a small potential benefit, with important harms such as false positives.

Does a full-body MRI find every cancer?

No. The American College of Radiology (2023) says there is no documented evidence that total-body screening prolongs life, and it often finds harmless incidental findings. It does not replace the cancer-specific tests recommended for your age.

What happens if screening finds something?

A finding is a reason to look closer, not a diagnosis. Whether a nodule or cyst needs no follow-up, repeat imaging or further testing depends on its location, size, features and your risk. A suspicious finding may need more imaging or a biopsy; how follow-up is arranged is confirmed for your booking.

Screen smart. Travel once. Know where you stand.

Compare screening packages, see exactly what each one includes, or talk to a coordinator about fitting Cancer screening into your visit to Taiwan.